Cancer News and Research

Latest Cancer News and Research

Distribution of human tumor mutations more similar to that of chimpanzees, gorillas

A new study by researchers from the Institute of Evolutionary Biology (IBE), a joint centre of UPF and the Spanish National Research Council (CSIC), shows that, surprisingly, the distribution of mutations in human tumours is more similar to that of chimpanzees and gorillas than that of humans.

21 May 2020

Next-gen nano technologies set to transform the medical industry

Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars under the National Health and Medical Research Council 2021 Investigator Grants.

21 May 2020

Scientists create a detailed map of how carcinogens trigger breast cancer development

In the most comprehensive review to date of how breast cancer develops, scientists have created a detailed map that describes the many ways in which environmental chemicals can trigger the disease.

21 May 2020

Just a little physical activity can have big impact for women with high-risk breast cancer

Results of a comprehensive analysis of exercise and its protective role for high-risk breast cancer patients show that women who exercise not only live longer, but also are more likely to remain cancer-free after their treatment. What's more, the study suggests that even a modest amount of exercise can be beneficial.

21 May 2020

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

By employing an immunoinformatics approach, a new study available on the preprint server bioRxiv* shows how the combination of peptides designed from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid phosphoprotein and spike glycoprotein may trigger an improved immunological response with respectable safety profile, informing, in turn, further vaccine development.

21 May 2020

Cell-culture based in vitro test systems for antitumor drug screening

As we know, a malignant tumor is a complex system of mutated cells which constantly interacts with and involves healthy cells in the body.

21 May 2020

Researchers receive $5.75 million to study link between obesity, inflammation and pancreatic cancer

A team of researchers from the UCLA Jonsson Comprehensive Cancer Center and peer institutions has been awarded a $5.75 million grant from the National Cancer Institute to study the correlation between obesity, inflammation and pancreatic cancer.

21 May 2020

UBC scientists discover gene that plays a role in resisting weight gain

Why can some people eat as much as they want, and still stay thin?

21 May 2020

Scientists use new model to develop cancer stem cells

Liver cancer is one of the deadliest cancers. It is insidious and does not present symptoms until it has progressed considerably, at which point, treatment options are limited and chances of survival are low. The most common type of liver cancer is hepatocellular carcinoma (HCC).

21 May 2020

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

21 May 2020

Producing virus-specific antibodies after COVID-19

In order to design effective vaccines for COVID-19, we need to understand our immune responses. News-Medical speaks to Professor Chen Dong to find out more.

21 May 2020

Research looks at COVID-19 in cancer patients

As the world grapples with the COVID-19 pandemic, new questions arise as to the risk posed by the virus to different patient populations, including the elderly and those with underlying disease. A new study published on the preprint server medRxiv* in May 2020 deals with the risk of COVID-19 in the subgroup of patients with cancer.

21 May 2020

Lattice light-sheet microscopy could help in drug and vaccine development

From testing drugs to developing vaccines, the close study of the immune system is key to improving real-world health outcomes. T-cells are integral to this research, as these white blood cells help tailor the body's immune response to specific pathogens.

21 May 2020

Magnetic core-shell iron nanowires can be used for noninvasive medical imaging

Living cells inside the body could be placed under surveillance--their location and migration noninvasively tracked in real time over many days--using a new method developed by researchers at KAUST.

20 May 2020

Experts urge further improvements in COVID-19 testing to increase speed and availability

In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.

20 May 2020

MIT researchers describe new methods for accelerating drug approvals during pandemics

In response to the COVID-19 pandemic, researchers from the Massachusetts Institute of Technology have published a pair of studies in a COVID-19 special issue of the Harvard Data Science Review, freely available via open access, describing new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines and other anti-infective therapies.

20 May 2020

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

PrECOG, LLC is reporting clinical efficacy and biomarker analyses from its single-arm phase two study PrE0505 for the initial treatment of patients with malignant pleural mesothelioma.

20 May 2020

Molecular testing rates in most countries less than 50%, IASLC survey finds

Access to targeted therapies for lung cancer depends on accurate identification of patients' biomarkers through molecular testing, but survey results published today in the Journal of Thoracic Oncology suggest that many international clinicians are unaware of evidence-based guidelines that support the use of molecular testing.

20 May 2020

Complex analytical methods contribute to variability of research outcomes

A new Tel Aviv University-led study published on May 20 in Nature offers new evidence that the complexity of contemporary analytical methods in science contributes to the variability of research outcomes.

20 May 2020

New technique reveals potentially treatable mutations in subset of prostate cancer patients

Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable mutations in their DNA damage-repair genes, according to research published in the May issue of The Journal of Nuclear Medicine.

20 May 2020

Cancer News and Research

Latest Cancer News and Research

Distribution of human tumor mutations more similar to that of chimpanzees, gorillas

Next-gen nano technologies set to transform the medical industry

Scientists create a detailed map of how carcinogens trigger breast cancer development

Just a little physical activity can have big impact for women with high-risk breast cancer

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

Cell-culture based in vitro test systems for antitumor drug screening

Researchers receive $5.75 million to study link between obesity, inflammation and pancreatic cancer

UBC scientists discover gene that plays a role in resisting weight gain

Scientists use new model to develop cancer stem cells

Comprehensive review of clioquinol drug gives valuable insights

Producing virus-specific antibodies after COVID-19

Research looks at COVID-19 in cancer patients

Lattice light-sheet microscopy could help in drug and vaccine development

Magnetic core-shell iron nanowires can be used for noninvasive medical imaging

Experts urge further improvements in COVID-19 testing to increase speed and availability

MIT researchers describe new methods for accelerating drug approvals during pandemics

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Molecular testing rates in most countries less than 50%, IASLC survey finds

Complex analytical methods contribute to variability of research outcomes

New technique reveals potentially treatable mutations in subset of prostate cancer patients

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in